ClinicalTrials.Veeva

Menu

POEM: Long vs Short Myotomy for Achalasia. RCT

C

Catholic University of the Sacred Heart

Status

Unknown

Conditions

Achalasia

Treatments

Procedure: Peroral Endoscopic Myotomy (POEM)

Study type

Interventional

Funder types

Other

Identifiers

NCT03450928
POEMLvS

Details and patient eligibility

About

Per-Oral Endoscopic Myotomy (POEM) is increasingly used for the treatment of achalasia. In published series, a 12cm-POEM is usually performed. Surgical myotomy is typically shorter (8cm). The clinical efficacy of both procedure is comparable.

This study intends to investigate if clinical outcomes of POEM depends on the length of esophageal myotomy, in patients with classic-type achalasia (type I and type II according to Chicago Classification)

Full description

Peroral Endoscopic Myotomy myotomy (POEM) has been recently introduced for treatment of achalasia, based on technical developments from NOTES (natural orifice translumenal surgery). The technique includes the incision of the mucosa in the esophageal body, the submucosal dissection of the distal esophagus and the creation of a submucosal tunnel in the distal esophagus and proximal gastric body, and the esophageal myotomy. The procedure is performed transorally, using a flexible endoscope.

In published series, a 12cm-POEM is usually performed. Surgical myotomy is typically shorter, being protracted for about 8cm. The clinical efficacy of POEM and surgical myotomy is more likely to be similar according to the most recent published series.

In this randomized controlled trial (non-inferiority trial) we evaluate the outcomes of POEM according to the length of the esophageal myotomy.

Patients with type I and II achalasia will be randomly assigned to one of the two groups, long--myotomy (LM) and short--myotomy (SM).

Patients in the LM-group will receive a 12cm-long POEM (including 3cm on the stomach); in the SM-group patients will undergo a POEM extended for 7 cm (including 3cm on the stomach).

During follow-up, High Resolution Manometry (HRM), Esophageal pH-monitoring study and Esophagogastroduodenoscopy (EGD) will be regularly performed and symptoms assessed with the use of the Eckardt score (ECKs).

The main hypothesis is that the results of a SM are not inferior to the results of a LM. Calculated sample size is 200 patients

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosis of achalasia (type I and II)
  2. Age > 18
  3. Signed informed consent
  4. Patient accepts to undergo scheduled follow-up after POEM
  5. Eckardt score > 3
  6. ASA I-II-III

Exclusion criteria

  1. Prior surgical treatment of achalasia (previous endoscopic balloon dilation or botox injection ARE NOT exclusion criteria)
  2. Pregnancy or nursing
  3. Current alcohol or drug addiction.
  4. Mentally retarded or emotionally unstable, or exhibits psychological characteristics which, in the opinion of the investigator make the subject a poor candidate for this study.
  5. Severe congenital or acquired coagulopathy or INR > 1.6
  6. Participating in another ongoing clinical trial in which concomitant diagnosis or therapeutic intervention would adversely affect the integrity of the clinical trial.
  7. Hepatic cirrhosis w/ or w/o portal hypertension w/ or w/o esophageal varices
  8. Eosinophilic esophagitis or Barrett Esophagus
  9. Esophageal Strictures

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Short POEM
Active Comparator group
Description:
Patients in the Short POEM-group will undergo a Peroral Endoscopic Myotomy (POEM) extended for a total of 7 cm (including 4 cm above the esophago-gastric junction and 3cm on the stomach).
Treatment:
Procedure: Peroral Endoscopic Myotomy (POEM)
Long POEM
Active Comparator group
Description:
Patients in the Long POEM-group will receive a 12cm-long Peroral Endoscopic Myotomy (POEM), including 9 cm on the esophagus and 3cm on the gastric wall
Treatment:
Procedure: Peroral Endoscopic Myotomy (POEM)

Trial contacts and locations

1

Loading...

Central trial contact

Pietro Familiari, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems